GlycoNex Incorporation (TPEX:4168)
Taiwan · Delayed Price · Currency is TWD 21.85
-0.30 (-1.35%)
Sep 8, 2026, 1:30 PM CST
GlycoNex Incorporation Market Cap
GlycoNex Incorporation has a market cap or net worth of 2.46 billion as of September 8, 2026. Its market cap has decreased by -13.28% in one year.
Market Cap
2.46B
Enterprise Value
2.37B
Revenue
22.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
21.85
ChartMarket Cap Chart
Since December 16, 2011, GlycoNex Incorporation's market cap has increased from 1.51B to 2.46B, an increase of 63.09%. That is a compound annual growth rate of 3.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 2.46B | -11.76% |
| Dec 31, 2025 | 2.79B | 2.79% |
| Dec 31, 2024 | 2.71B | -16.13% |
| Dec 29, 2023 | 3.23B | -0.89% |
| Dec 30, 2022 | 3.26B | 13.02% |
| Dec 30, 2021 | 2.89B | 3.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 3D Global Biotech | 3.07B |
| Senhwa Biosciences | 3.06B |
| Intech Biopharm | 2.97B |
| Chunghwa Chemical Synthesis & Biotech | 2.69B |
| Energenesis Biomedical CO.,LTD. | 2.68B |
| Anti-Microbial Savior BioteQ | 2.42B |
| Taiwan Bio Therapeutics | 2.21B |
| HeXun Biosciences | 2.16B |